Suggestions
Catherine Dubreuil
Program and Alliance manager
Professional Background
Catherine Dubreuil is a distinguished professional in the fields of biotechnology and academic education, with a strong focus on the comprehensive aspects of drug discovery and development. With her robust background in cellular biology and neurocytology, Catherine is adept at facilitating connections and launching initiatives that drive innovative programs forward. Her career is characterized by a deep partnership with pharmaceutical companies, biotech firms, government organizations, and academic institutions. This collaborative ethos has enabled her to create educational programs and internship opportunities that empower graduate students, postdoctoral fellows, and faculty members to navigate the complexities of drug development effectively.
Catherine's previous role in a biotech company honed her skills in supporting preclinical development for lead molecules, with particular emphasis on a compound that is currently advancing through Phase 2 clinical trials. This experience not only enriched her understanding of the drug development pipeline but also positioned her as a valuable asset in the academic realm, where she continuously works to bridge the gap between research and clinical application.
In her current capacity, Catherine serves as the Executive Director of the Harvard Therapeutics Graduate Program (TGP) at Harvard Medical School. Here, she plays a pivotal role in shaping the educational landscape for future leaders in therapeutics, ensuring that they are well-equipped with the knowledge and skills needed to succeed in this rapidly evolving field. Through strategic management and collaboration, Catherine has successfully led multiple projects, creating pathways for advancement in both academic and clinical research settings.
Education and Achievements
Catherine Dubreuil's educational journey began at the Université de Montréal, where she earned her Bachelor of Science (BSc) in Biology, focusing on Microbiology and Immunology. Her strong foundation in basic biological sciences paved the way for her pursuit of advanced studies, culminating in her PhD in Cell Biology, with a specialized concentration on molecular neurocytology. This rich academic background has awarded her unique insights into the mechanisms underlying neurodegeneration and central nervous system (CNS) disorders.
Throughout her career, Catherine has not only excelled in research but has also contributed significantly to education and training. Before her current role, she was the Director of Training and Education at the Ideation HUB (I-Hub) at Harvard Medical School. In this position, she curated educational initiatives that fostered an environment of learning and collaboration among aspiring scientists and researchers. Her experience as a lecturer in the Biological Chemistry and Molecular Pharmacology (BCMP) program at Harvard Medical School further solidified her reputation as an inspiring educator who is passionate about nurturing the next generation of biomedical scientists.
Notable Contributions
Catherine's extensive list of previous roles showcases her adaptability and expertise across various facets of scientific inquiry and education. She served as a Scientific Consultant at BioAxone BioSciences Inc, where her deep knowledge of therapy development influenced strategic decision-making processes. As a Curriculum Fellow at Harvard Medical School, she made substantial contributions to the curriculum design, ensuring that it met the emerging needs in life sciences education.
Moreover, her role as a postdoctoral fellow at both Harvard Medical School and the Dana-Farber Cancer Institute provided her with additional research experience in highly regarded institutions, further immersing her in cutting-edge scientific endeavors. As an Advising Scientist at BioAxone Therapeutic, Inc., Catherine's insights on therapeutic mechanisms and strategies were invaluable, helping guide the organization's research efforts.
Catherine Dubreuil's journey reflects a commitment to excellence in scientific research and education. Her ability to manage multiple projects, set strategic directions, and collaborate with diverse stakeholders sets her apart as a leader in her field. As she continues to foster connections between academia and industry, Catherine remains dedicated to elevating the educational experiences of students and trainees, ultimately contributing to advancements in drug discovery and development.
